Guillaume Cartron

36PUBLICATIONS
257CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 16, 2026
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL.

|Jul 03, 2026
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

|Mar 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Nicolas Gower, Pierre Feugier, Jason R Westin

|Feb 26, 2026
Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.

Paul Marcoux, Fabien Gava, Marie Tosolini

|Jan 09, 2026
Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma.

Emilie Charton, Amélie Anota, Emmanuel Bachy

Pageof 6

Frequent Collaborators

16 joint publications

Franck Morschhauser

13 joint publications

Emmanuel Bachy

13 joint publications

Roch Houot

8 joint publications

Steven Le Gouill